Bristol-Myers Squibb

Daklinza

DAKLINZA contains Drug / Molecule called “DACLATASVIR”. It is used for the treatment of patients with chronic Hepatitis C virus (HCV).It inhibits the Hepatitis C Virus (HCV) nonstructural protein; by targeting two steps of the viral replication process, enabling rapid decline of HCV RNA.

Details
Specification

Indication

DACLATASVIR is used for treatment of patients with chronic Hepatitis C .

Note

Precaution

Cases of severe bradycardia and heart block have been observed when used in combination with sofosbuvir with or without other drugs that lower heart rate.
Daklinza should not be used during pregnancy or in women of childbearing potential not using contraception.

Updated On Oct 19, 2019 by Admin